A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis-Reference-Cited by-同舟云学术

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis

Published:2021-02-22 Issue:7 Volume:60 Page:943-953
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

van Beek Stijn W.^ORCID,ter Heine Rob,Alffenaar Jan-Willem C.,Magis-Escurra Cecile,Aarnoutse Rob E.,Svensson Elin M.,Boeree M. J.,Burhan E.,Dawson R.,Diacon A. H.,Gillespie S.,Mtabho C. M.,Ntingiya N. E.,Heinrich N.,Hoefsloot W.,Hoelscher M.,Kibiki G.,Reither K.,Sanne I.,Semvua H. H.,Tostmann A.,

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-020-00971-2.pdf

Reference49 articles.

1. World Health Organization. Global tuberculosis report 2019. http://www.who.int/tb/publications/global_report/en/. Accessed 7 Dec 2020.

2. Alsultan A, Peloquin CA. Therapeutic drug monitoring in the treatment of tuberculosis: an update. Drugs. 2014;74(8):839–54.

3. World Health Organization. Essential medicines list. 20th ed. 2017. http://www.who.int/medicines/publications/essentialmedicines/en/. Accessed 7 Dec 2020.

4. Wilkins JJ, Landon G, McIlleron H, et al. Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients. Br J Clin Pharmacol. 2011;72(1):51–62.

5. Sundell J, Bienvenu E, Janzén D, et al. Model-based assessment of variability in isoniazid pharmacokinetics and metabolism in patients co-infected with tuberculosis and HIV: implications for a novel dosing strategy. Clin Pharmacol Ther. 2020;108(1):73–80.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Interindividual Variability in Metabolic Clearance and Relative Bioavailability on Rifampicin Exposure in Tuberculosis Patients with and without HIV Co-Infection: Does Formulation Quality Matter?;Pharmaceutics;2024-07-23

2. Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection;Journal of Antimicrobial Chemotherapy;2024-04-25

3. Síntesis de tioureas con isoniacida y niacida estructural: test frente a bacterias Gram + y Gram –;Revista Colombiana de Química;2024-02-05

4. Towards Model-Informed Precision Dosing of Voriconazole: Challenging Published Voriconazole Nonlinear Mixed-Effects Models with Real-World Clinical Data;Clinical Pharmacokinetics;2023-08-21

5. Limited sampling strategies for therapeutic drug monitoring of anti-tuberculosis medications: A systematic review of their feasibility and clinical utility;Tuberculosis;2023-07